top of page

A world-first report on natural compounds that directly disrupt SARS-CoV-2 viral proteins—beyond the reach of conventional antivirals.

This study focuses on three viral proteins believed to persist in the body after infection: ORF3a, ORF9b, and the Spike S1 N-terminal domain (S1-NTD).

  • ORF3a forms destructive “pores” in lysosomes and the Golgi apparatus, impairing the cell’s self-cleaning function (autophagy).

  • ORF9b fuses with TOM70, a receptor on the outer membrane of mitochondria, disrupting both immune signaling and energy production.

  • S1-NTD exhibits high neuroinvasiveness and has been implicated in multi-organ inflammation and autoimmune-like symptoms.

The compounds evaluated in this report are all naturally derived and have shown potential not only for mitochondrial protection, synaptic plasticity, and cytokine balance, but also for general neuroimmune homeostasis.

Our methodology combines molecular dynamics simulation (OpenMM, developed by Stanford) and force field optimization (OpenFF), with a retrained and modified version of DeepPurpose (originally developed at Harvard). This was integrated with the latest UC San Diego COVID-19 drug-target dataset (14,493 entries as of December 2024), enabling drug-level molecular screening at unprecedented speed and accuracy.

 

Key Biological Targets

  • Structural destabilization of viral proteins known to impair autophagy

  • Interference with mitochondrial outer membrane complexes (e.g., ORF9b–TOM70)

  • Indirect blockade of S1-NTD binding sites that impact immune and neural stability

  • Evaluation of antioxidant, anti-inflammatory, and neuroprotective auxiliary pathways

 

Who Should Read This Report

  • Individuals in good health seeking to optimize focus, cognitive endurance, and sustained energy

  • People experiencing brain fog, fatigue, or cognitive decline after COVID-19 infection

  • Those seeking a holistic strategy for post-viral neuroimmune-metabolic recovery

  • Users who prefer natural, low-risk, functionally backed supplements

  • Healthcare professionals and researchers seeking quantitative, simulation-based supplement evaluation

 

Important Precautions (Consult your doctor)

  • Pregnant or breastfeeding individuals

  • Those with a history of hormone-sensitive conditions (e.g., breast or prostate cancer)

  • Individuals currently taking anticoagulants, immunosuppressants, or antidepressants (possible interactions)

  • People sensitive to high doses of antioxidants

  • Individuals with severe liver or kidney disorders

 

Disclaimer

This report is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment.
Always consult a qualified healthcare professional before making decisions regarding supplements or health interventions.

Frontline Natural Molecules Against SARS-CoV-2 Proteins: Immunity, Mitochondria

€300.00価格
  • Language : English

    Report number : 62

    Category : Viral Proteins

    Format : PDF

    Pages : 76

    Subject : World, Now

    Period analyzed : ~April 2025

分析内容に関する質問などはこちらからどうぞ

Thanks for submitting!

© 2026 by Fukushima Diary srl. Proudly created with Wix.com

Angamareport

 コロナウイルス ミトコンドリア

特定商取引法に基づく表記

・販売事業者
Fukushima Diary SRL

・運営責任者
望月 伊織

・所在地
ルーマニア
※所在地の詳細については、ご請求があった場合には遅滞なく開示いたします。

・電話番号
※電話番号については、ご請求があった場合には遅滞なく開示いたします。

・連絡先
メールアドレス:fukushimadiary.official@gmail.com
※お問い合わせは上記メールアドレスまたはサイト内お問い合わせフォームよりお願いいたします。

・販売価格
各商品ページに記載のとおり(税込)

・商品代金以外の必要料金
なし(デジタル商品のため送料は発生しません)

・支払い方法
Wix Payments(クレジットカード等)

・支払い時期
ご注文確定時にお支払いが確定します

・商品の引渡し時期
決済完了後、直ちにダウンロード可能です

・返品・返金について
デジタル商品の性質上、購入確定後のお客様都合による返品・返金はお受けしておりません。
ただし、ダウンロード不能、ファイル破損、商品内容に重大な瑕疵がある場合は、購入後7日以内にご連絡ください。
詳細は「返金および返品ポリシー」をご確認ください。
https://www.angamareport.com/downloads-refunds

・商品内容について
本商品は情報提供を目的としたデジタルコンテンツです。
医療行為、診断、治療、または治療効果の保証を目的とするものではありません。
詳細は「ストアポリシー」をご確認ください。
https://www.angamareport.com/store-policy

bottom of page